Washington Mitragynine Pseudoindoxyl Ban (2026): In Force
Ban in force
As of November 12, 2026, Mitragynine Pseudoindoxyl is banned from retail sale in Washington. The ban comes from federal scheduling, which takes precedence over state law.
When does the Washington Mitragynine Pseudoindoxyl ban take effect?
The Washington Mitragynine Pseudoindoxyl ban is already in force; no further effective date is pending.
Hotearliest DEA action in 0 days (DEA-1570 / FR 2026-20943); notice of intent by the DEA (Drug Enforcement Administration), applies to every seller; emergency rule by the DEA (Drug Enforcement Administration), applies to every seller
active DEA notice of intent to issue a new temporary order keeping MGM-15 and MGM-16 in Schedule I without a threshold Federal · Notice of intent · DEA-1644; FR Doc. 2026-20942 · DEA (Drug Enforcement Administration) · applies to every seller DEA will issue a fresh two-year temporary order for MGM-15 and MGM-16 (no threshold) so they are separated from the thresholded pseudoindoxyl rule; the August 26, 2026 order stays in force until the new order publishes or expires August 26, 2028.
active DEA temporary scheduling order places mitragynine pseudoindoxyl, MGM-15 and MGM-16 in Schedule I for two years Federal · Emergency rule · DEA-1644; 91 FR 54948; FR Doc. 2026-17429 · DEA (Drug Enforcement Administration) · applies to every seller Mitragynine pseudoindoxyl, MGM-15 (dihydro-7-hydroxymitragynine) and MGM-16 (9-fluoro-dihydro-7-hydroxymitragynine), with isomers, esters, ethers and salts, became Schedule I effective August 26, 2026 through August 26, 2028; DOJ announced enforcement discretion for incidental trace pseudoindoxyl in botanical kratom.
Show 2 more pending items
active Notice of intent to temporarily schedule mitragynine pseudoindoxyl, MGM-15 and MGM-16 Federal · Notice of intent · FR 2026-13581 / 91 FR 40909 · DEA (U.S. Drug Enforcement Administration) · advisory, not binding Order "will be published in the Federal Register on or after August 5, 2026" and takes effect on publication. This is the single highest-value watch item for pseudoindoxyl -- it would replace interpretive isomer capture in AL, AR, IN and WI with a NAMED federal basis. Speciociliatine is in NEITHER docket.
Compound Analytics. "Washington Mitragynine Pseudoindoxyl Ban (2026): In Force." Compound Laws, https://compoundlaws.com/bans/pseudoindoxyl/washington/. Accessed November 13, 2026.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.